|
1
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
2
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: a link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang XZ, Wang J, Huang C, et al: Emodin
enhances cytotoxicity of chemotherapeutic drugs in prostate cancer
cells: the mechanisms involve ROS-mediated suppression of multidrug
resistance and hypoxia inducible factor-1. Cancer Biol Ther.
7:468–475. 2008. View Article : Google Scholar
|
|
4
|
Walczak H, Miller RE, Ariail K, et al:
Tumoricidal activity of tumor necrosis factor-related
apoptosis-inducing ligand in vivo. Nat Med. 5:157–163. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walczak H, Bouchon A, Stahl H and Krammer
PH: Tumor necrosis factor-related apoptosis-inducing ligand retains
its apoptosis-inducing capacity on Bcl-2- or
Bcl-xL-overexpressing chemotherapy-resistant tumor
cells. Cancer Res. 60:3051–3057. 2000.PubMed/NCBI
|
|
6
|
Zhang L and Fang B: Mechanisms of
resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther.
12:228–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hellwig CT and Rehm M: TRAIL signaling and
synergy mechanisms used in TRAIL-based combination therapies. Mol
Cancer Ther. 11:3–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song IS, Jun SY, Na HJ, et al: Inhibition
of MKK7-JNK by the TOR signaling pathway regulator-like protein
contributes to resistance of HCC cells to TRAIL-induced apoptosis.
Gastroenterology. 143:1341–1351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ravipati AS, Zhang L, Koyyalamudi SR, et
al: Antioxidant and anti-inflammatory activities of selected
Chinese medicinal plants and their relation with antioxidant
content. BMC Complement Altern Med. 12:1732012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao H, Huang YN, Gao B, Xu PY, Inagaki C
and Kawabata J: α-Glucosidase inhibitory effect by the flower buds
of Tussilago farfara L. Food Chemistry. 106:1195–1201.
2008.
|
|
11
|
Park HR, Yoo MY, Seo JH, et al:
Sesquiterpenoids isolated from the flower buds of Tussilago
farfara L. inhibit diacylglycerol acyltransferase. J Agric Food
Chem. 56:10493–10497. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scordino M, Sabatino L, Traulo P, Gargano
M, Panto V and Gagliano G: HPLC-PDA/ESI-MS/MS detection of
polymethoxylated flavones in highly degraded citrus juice: a
quality control case study. Eur Food Res Technol. 232:275–280.
2011. View Article : Google Scholar
|
|
13
|
Falschlehner C, Emmerich CH, Gerlach B and
Walczak H: TRAIL signalling: decisions between life and death. Int
J Biochem Cell Biol. 39:1462–1475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin Z, McDonald ER III, Dicker DT and
El-Deiry WS: Deficient tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL) death receptor transport to the
cell surface in human colon cancer cells selected for resistance to
TRAIL-induced apoptosis. J Biol Chem. 279:35829–35839. 2004.
View Article : Google Scholar
|
|
15
|
Vogl S, Picker P, Mihaly-Bison J, et al:
Ethnopharmacological in vitro studies on Austria’s folk medicine -
an unexplored lore in vitro anti-inflammatory activities of 71
Austrian traditional herbal drugs. J Ethnopharmacol. 149:750–771.
2013.
|
|
16
|
Didry N, Pinkas M and Torck M: Phenolic
components from Tussilago farfara. Ann Pharm Fr. 38:237–241.
1980.(In French).
|
|
17
|
Batra P and Sharma AK: Anti-cancer
potential of flavonoids: recent trends and future perspectives.
Biotech. 3:439–459. 2013.
|
|
18
|
Chen KF, Yeh PY, Hsu C, et al: Bortezomib
overcomes tumor necrosis factor-related apoptosis-inducing ligand
resistance in hepatocellular carcinoma cells in part through the
inhibition of the phosphatidylinositol 3-kinase/Akt pathway. J Biol
Chem. 284:11121–11133. 2009. View Article : Google Scholar
|
|
19
|
Shin EC, Seong YR, Kim CH, et al: Human
hepatocellular carcinoma cells resist to TRAIL-induced apoptosis,
and the resistance is abolished by cisplatin. Exp Mol Med.
34:114–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
